about me

I am a designer and developer based in London, UK, specialising in start ups and health tech companies. I am a former pharmacy student at King’s College London and have been working at a mental health MedTech startup. I worked at hospitals as an interpreter, a placement student, a volunteer for over 8 years. Outside of work, you can find me travelling, taking photography, obsessed with fashion or creating art!

I am a designer and developer based in London, UK, specialising in start ups and health tech companies. I am a former pharmacy student at King’s College London and have been working at a mental health MedTech startup. I worked at hospitals as an interpreter, a placement student, a volunteer for over 8 years. Outside of work, you can find me travelling, taking photography, obsessed with fashion or creating art!

A thoughtful young woman

my experience

my experience

my experience

Calibris (King's College London IoPPN)

Product Developer & Research Assistant

Digitalised a research-validated wellbeing intervention into an app, supervised by Dr Jenny Yiend, King's College London (IoPPN). Intended to meet dtac-compliance. Contributed to feature development, content, and quality assurance across the team.

2026 - present

Calibris (King's College London IoPPN)

Product Developer & Research Assistant

2026 - present

Vela

Founder

Designed and built a medication-adherence app for patients and clinicians, end to end, with a NICE-guideline-based triage algorithm that flags when a GP review is needed.

2026 - present

Vela

Founder

2026 - present

Freelance (UBER AI, Outlier AI)

AI data annotator and trainer

Evaluated LLM outputs for accuracy, consistency, and compliance, and flagged systemic hallucination patterns across model responses.

2024 - 2025

Freelance (UBER AI, Outlier AI)

AI data annotator and trainer

2024 - 2025

Freelance (UBER AI, Outlier AI)

AI data annotator and trainer

Evaluated LLM outputs for accuracy, consistency, and compliance, and flagged systemic hallucination patterns across model responses.

2024 - 2025